Clinical Trial Update: Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether somatostatin infusion after hepatectomy reduces postoperative ascites in hepatocellular carcinoma. The study is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Somatostatin (somatostatin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED